Roche Holdings AG RHHBY on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases. Highlights included presentations from the ongoing trontinemab Phase 1b/2a Brainshuttle AD study, which …

The test, funded by the Alzheimer's Society and Alzheimer's Research UK, used light-based technology to detect protein levels in the blood linked to the illness. The researchers were also developing a handheld device that could provide results …

Alzheimer's research has made significant progress and advancements in the past decade, led by a greater investment in Alzheimer's-related studies. In 2024, research determined one particular biomarker in blood tests strongly correlated with the …

It wasn't that long ago that the only way to test for Alzheimer's disease was to perform an autopsy on someone who had been suffering from dementia to look for the telltale tangles of tau and amyloid proteins in the brain. While these tangles are …

When doctors suspect Alzheimer's, they can order a blood test to learn whether a patient's brain contains the sticky amyloid plaques that are a hallmark of the disease. But the results of that test won't tell the whole story, says Dr. Randall …

Researchers at Karolinska Institutet have demonstrated how specific biomarkers in the blood can predict the development of dementia up to ten years before diagnosis, among older adults living independently in the community. A new study, published in Nature …

Scientists have developed a blood test for Alzheimer’s disease that can help diagnose the neurodegenerative disease while also indicating how far it has progressed. The results could help doctors decide which medications to prescribe depending on how long …

Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease. A team from the University of Barcelona has developed a promising therapeutic …

Around 10 million people are diagnosed with some form of dementia worldwide each year, a figure that has been increasing at an unprecedented rate in recent years. Studies also predict that number will increase by 2050, according to the site science alert. …

A federal district court has struck a blow for medical innovation and patient empowerment by overruling the Food and Drug Administration's (FDA) misbegotten effort to regulate laboratory-developed (LDTs) and in vitro testing. LDTs are diagnostic in …